TrialAnnals of surgical oncology2023

Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial.

C Bakkers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.